Lumida
/ACAD
⌘K
ACADIA Pharmaceuticals Inc

ACADIA Pharmaceuticals Inc

ACAD
$27.83USD+0.32%+0.09 today

MARKET CAP

4.8B

P/E (TTM)

12.1x

FWD P/E

DAY RANGE

$28 – $28

52W RANGE

$20
$31

AI Summary

Stalk
Sell NowMedium

ACAD is forming a series of lower highs and lower lows beneath falling EMAs, confirming a Medium-Term bearish bias within the broader uptrend. The recent rally into the 9/20 EMA zone is facing resistance, offering a tactical opportunity to sell now on the bounce. Short-Term execution favors selling into dynamic resistance, while the 200 DMA uptrend supports the longer-term bull case but remains overshadowed by current distribution.

  • Q2 2026 revenue $308M (+17% YoY), driven by Debut & New Placid
  • Debut net sales $125M (+30% YoY); New Placid $183M (+10% YoY)
  • Earnings yield at ~0.07% signals costly entry point
Full analysis →
Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income